As per this study the Global Pneumococcal Vaccine Market was valued USD XXX MN (by revenue) in 2018 and is anticipated to reach USD XXX MN by 2025 with a CAGR of X.X%.
Pneumococcal vaccine helps to protect against pneumococcal infections which are most common in kids. Pneumococcal vaccine is categorized into pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23). Pneumococcal conjugate vaccine (PCV13) is given to all infants as a series of four injections the first at 2 months of age, then at 4 months, 6 months, and 12–15 months and PPSV23 vaccines are recommended as additional protection against pneumococcal disease in kids of 2–18 years old who have certain chronic health problems. PCV13 protects against 13 types of pneumococcal bacteria whereas PPSV23 protects against 23 types.
Rising efforts by the government in order to provide vaccination around the globe along with the increasing cases of pneumococcal diseases due to causative serotype drives need for vaccines is expected to foster the market growth. Advent of pneumococcal vaccines with wider serotype coverage and rising participation of government and non-profit organization for availability, supply, and distribution of pneumococcal vaccines in the developing region is also expected to augment market growth. Whereas, the high cost of vaccines and the entry of new vaccines are anticipated to limit the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of pneumococcal vaccine.
The broad pneumococcal vaccine market has been sub-grouped into product type and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product Type
By Distribution Channel
- Pneumococcal Polysaccharide Vaccines
- Pneumococcal Conjugate Vaccines
- Community Clinics
- Public Health Agencies
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for pneumococcal vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Pneumococcal Vaccine Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the pneumococcal vaccine market includes GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
2. EXECUTIVE SUMMARY
- Introduction To Pneumococcal Vaccine
- Report Description
- Objectives Of The Study
- Research Scope
- Research Methodology
3. MARKET ANALYSIS
- Market Highlight
- Global Pneumococcal Vaccine Market: Snapshot
4. PNEUMOCOCCAL VACCINE MARKET ANALYSIS BY PRODUCT TYPE
- Porter’s Five Forces Analysis
- Value Chain Analysis
5. PNEUMOCOCCAL VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- Market In Pneumococcal Polysaccharide Vaccines
- Market In Pneumococcal Conjugate Vaccines
6. PNEUMOCOCCAL VACCINE MARKET ANALYSIS BY GEOGRAPHY
- Market In Pharmacies
- Market In Community Clinics
- Market In Public Health Agencies
- Market In Others
7. COMPETITIVE LANDSCAPE OF THE PNEUMOCOCCAL VACCINE COMPANIES
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
8. COMPANY PROFILES OF THE PNEUMOCOCCAL VACCINE INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- Market Competition
- Mergers And Acquisitions
- New Product Launches
- Other Developments
* Tentative TOC
LIST OF TABLES
- GlaxoSmithKline Plc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
Table 1. Market Highlights Of Pneumococcal Vaccine
Table 2. Global Pneumococcal Vaccine Market By Product Type
Table 3. Global Pneumococcal Vaccine Market By Distribution Channel
Table 4. Global Pneumococcal Vaccine Market By Geography
Table 5. North America Pneumococcal Vaccine Market
Table 6. Europe Pneumococcal Vaccine Market
Table 7. Asia Pacific Pneumococcal Vaccine Market
Table 8. Latin America Pneumococcal Vaccine Market
Table 9. Middle East And Africa Pneumococcal Vaccine Market
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Pneumococcal Vaccine Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Pneumococcal Vaccine
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 9. Global Pneumococcal Vaccine Market By Product Type
Fig. 10. Global Pneumococcal Vaccine Market By Distribution Channel
Fig. 11. Global Pneumococcal Vaccine Market By Geography
Fig. 12. North America Pneumococcal Vaccine Market
Fig. 13. Europe Pneumococcal Vaccine Market
Fig. 14. Asia Pacific Pneumococcal Vaccine Market
Fig. 15. Latin America Pneumococcal Vaccine Market
Fig. 16. Middle East And Africa Pneumococcal Vaccine Market
Fig. 17. Market Share Of Pneumococcal Vaccine Companies
Fig. 18. Recent Developments In Pneumococcal Vaccine Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.